These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37942479)

  • 21. Construction and characterization of two SARS-CoV-2 minigenome replicon systems.
    Zhang H; Fischer DK; Shuda M; Moore PS; Gao SJ; Ambrose Z; Guo H
    J Med Virol; 2022 Jun; 94(6):2438-2452. PubMed ID: 35137972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SARS-CoV-2 replicon for high-throughput antiviral screening.
    Zhang QY; Deng CL; Liu J; Li JQ; Zhang HQ; Li N; Zhang YN; Li XD; Zhang B; Xu Y; Ye HQ
    J Gen Virol; 2021 May; 102(5):. PubMed ID: 33956592
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
    Zhang Y; Song W; Chen S; Yuan Z; Yi Z
    Antiviral Res; 2021 Jan; 185():104974. PubMed ID: 33217430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid cloning-free mutagenesis of new SARS-CoV-2 variants using a novel reverse genetics platform.
    Kipfer ET; Hauser D; Lett MJ; Otte F; Urda L; Zhang Y; Lang CMR; Chami M; Mittelholzer C; Klimkait T
    Elife; 2023 Nov; 12():. PubMed ID: 37988285
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-throughput assay using a GFP-expressing replicon for SARS-CoV drug discovery.
    Ge F; Xiong S; Lin FS; Zhang ZP; Zhang XE
    Antiviral Res; 2008 Nov; 80(2):107-13. PubMed ID: 18584889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A BSL-2 compliant mouse model of SARS-CoV-2 infection for efficient and convenient antiviral evaluation.
    Chen Z; Cui Q; Ran Y; Achi JG; Chen Z; Rong L; Du R
    J Virol; 2024 Jun; ():e0050424. PubMed ID: 38899934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reverse genetic systems of SARS-CoV-2 for antiviral research.
    Kurhade C; Xie X; Shi PY
    Antiviral Res; 2023 Feb; 210():105486. PubMed ID: 36657881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reverse genetics systems for SARS-CoV-2.
    Wang W; Peng X; Jin Y; Pan JA; Guo D
    J Med Virol; 2022 Jul; 94(7):3017-3031. PubMed ID: 35324008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engineering a replication-competent, propagation-defective Middle East respiratory syndrome coronavirus as a vaccine candidate.
    Almazán F; DeDiego ML; Sola I; Zuñiga S; Nieto-Torres JL; Marquez-Jurado S; Andrés G; Enjuanes L
    mBio; 2013 Sep; 4(5):e00650-13. PubMed ID: 24023385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Infectious cDNA Clone of SARS-CoV-2.
    Xie X; Muruato A; Lokugamage KG; Narayanan K; Zhang X; Zou J; Liu J; Schindewolf C; Bopp NE; Aguilar PV; Plante KS; Weaver SC; Makino S; LeDuc JW; Menachery VD; Shi PY
    Cell Host Microbe; 2020 May; 27(5):841-848.e3. PubMed ID: 32289263
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of Non-infectious SARS-CoV-2 Replicons and Their Application in Drug Evaluation.
    Wang B; Zhang C; Lei X; Ren L; Zhao Z; Wang J; Huang H
    Virol Sin; 2021 Oct; 36(5):890-900. PubMed ID: 33835389
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A PCR amplicon-based SARS-CoV-2 replicon for antiviral evaluation.
    Kotaki T; Xie X; Shi PY; Kameoka M
    Sci Rep; 2021 Jan; 11(1):2229. PubMed ID: 33500537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-Virus Chimeric Events in SARS-CoV-2-Infected Cells Are Infrequent and Artifactual.
    Yan B; Chakravorty S; Mirabelli C; Wang L; Trujillo-Ochoa JL; Chauss D; Kumar D; Lionakis MS; Olson MR; Wobus CE; Afzali B; Kazemian M
    J Virol; 2021 Jul; 95(15):e0029421. PubMed ID: 33980601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid identification of coronavirus replicase inhibitors using a selectable replicon RNA.
    Hertzig T; Scandella E; Schelle B; Ziebuhr J; Siddell SG; Ludewig B; Thiel V
    J Gen Virol; 2004 Jun; 85(Pt 6):1717-1725. PubMed ID: 15166457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Simplified SARS-CoV-2 Mouse Model Demonstrates Protection by an Oral Replicon-Based mRNA Vaccine.
    Jawalagatti V; Kirthika P; Hewawaduge C; Park JY; Yang MS; Oh B; So MY; Kim B; Lee JH
    Front Immunol; 2022; 13():811802. PubMed ID: 35250985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351).
    Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S
    Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
    Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
    J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A mouse model for Betacoronavirus subgroup 2c using a bat coronavirus strain HKU5 variant.
    Agnihothram S; Yount BL; Donaldson EF; Huynh J; Menachery VD; Gralinski LE; Graham RL; Becker MM; Tomar S; Scobey TD; Osswald HL; Whitmore A; Gopal R; Ghosh AK; Mesecar A; Zambon M; Heise M; Denison MR; Baric RS
    mBio; 2014 Mar; 5(2):e00047-14. PubMed ID: 24667706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
    Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
    mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
    Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
    Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.